News Focus
News Focus
icon url

bow-tie

08/29/20 12:39 PM

#19996 RE: bow-tie #19995

Dipali Pathak, Baylor College of Medicine, pathak@bcm.edu

Dipali Pathak
I’ve been part of the Office of Communications and Community Outreach since May 2007 and as assistant director of communications-special projects, I work to communicate the important work and research of our faculty members within the Baylor community and beyond. Some of the areas that I cover include nutrition, psychiatry, orthopedic surgery, and news on all four of our schools at Baylor (medical school, Graduate School of Biomedical Sciences, School of Allied Health Sciences and National School of Tropical Medicine).
https://blogs.bcm.edu/contributors/profile-dipali-pathak/

Dipali Pathak - Integral University, Lucknow, Uttar Pradesh ...
in.linkedin.com/in/dipali-pathak-72a0761b6
Student at Integral University, Lucknow, Uttar Pradesh Lucknow, ... Special Projects at Baylor College of Medicine. Houston, Texas Area. Dipali Pathak. Dipali Pathak

Location: Lucknow, Uttar Pradesh, India
icon url

Work Harder

08/29/20 1:48 PM

#19998 RE: bow-tie #19995

Compositions comprising antigen-complexes, method of making same as well as methods of using the antigen-complexes for vaccination

Inventor Antonius Johannes Stegmann Current Assignee Bestewil Holding BV

https://patents.google.com/patent/US20050214359#citedBy

Cited By (8)

Compositions for stimulation of mammalian innate immune resistance to pathogens

Current Assignee University of Texas System

https://patents.google.com/patent/US8883174B2/en

Compositions and methods for treating viral infections through stimulated innate immunity in combination with antiviral compounds

Current Assignee Pulmotect Inc Baylor College of Medicine University of Texas System

https://patents.google.com/patent/US10286065B2/en

Well, whada ya know :}

Now we know why the big mucky muck editor @ Texas U did the Rsv thang

I wonder who ??????????? in Chinese is being

Oakland United Services Ltd

which also cited it

Additionally

if no one thinks Springer doesn't know what this is about then we are all crazy LOL

https://adisinsight.springer.com/drugs/800021858

So, they are preparing to pick back up the Belgium trial but in men & women

Being a combined Phase I / II

market launch ibefore 2025 w/ fast track ?

&

potentially Malaria Path money